|
Growth inhibitory effect of Doxorubicin (ID50) with and without CCI-779 |
|||
| DOX (ug/ml) |
DOX+0.01 ug CCI-779 |
DOX+1 ug CCI-779 |
|
|
|
|||
| SCLCA |
0.09 ± 0.02 |
0.07 ± 0.01 |
0.08 ± 0.02 |
| SCLCR |
0.042 ± 0.01 |
0.058 ± 0.02 |
0.009 ± 0.005 |
Wu et al. Molecular Cancer 2005 4:25 doi:10.1186/1476-4598-4-25 |
|||